Institut Sainte-Catherine 250 Chemin de Baigne-Pieds_Investigational Site Number :2500005

Avignon 84918

0 studies enrolling now · 1 studies all time

What they study most

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Studies at this site

• Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC — Stopped early